证券代码：603843 证券简称：*ST 正平 公告编号：2025-102 正平路桥建设股份有限公司 关于公司预重整部分债权申报及部分子公司债权调查的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重大风险提示： ●本次预重整债权申报为部分债权申报，公司主要控股子公司未被纳入本次预重 整债权申报范围，债权申报准确性、完整性存在重大不确定性，公司可能难以通过本 次债权申报消除非标意见所涉事项。正平路桥建设股份有限公司（以下简称"公司" 或"正平股份"）预重整债权申报涉及母公司及部分子公司债权申报及调查，公司重 要控股子公司如贵州水利、贵州金九金、隆地电力等公司均未被纳入本次预重整债权 申报及债权调查范围。考虑到相关子公司业务规模较大，涉及债务较多，因相关公司 未被纳入预重整债权申报范围，公司可能难以通过本次预重整债权申报，消除 2024 年非标意见所涉及的工程项目成本费用、外部借款计量的准确性、完整性不足等事项。 ●公司不排除存在因资产减值、预重整债权申报发现应计而未计债务，导致 2025 年度经审计的归母净资产为负，从 ...

证券代码：603843 证券简称：*ST 正平 公告编号：2025-103 正平路桥建设股份有限公司 2025年第二次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | 股东类型 | 同意 | | 反对 | | 弃权 | | | --- | --- | --- | --- | --- | --- | --- | | | 票数 | 比例（%） | 票数 | 比例 （%） | 票数 | 比例 （%） | | A 股 | 251,003,439 | 99.5968 | 905,620 | 0.3593 | 110,540 | 0.0439 | 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 990 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 252,019,599 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 36.0222% | (四) 表决方式是否符合《 ...

令青海竞帆律师事务所 关于正平路桥建设股份有限公司 2025年第二次临时股东会之 法律意见书 Jf〃g／h〃C》加吗8I0000 青 海 竞 帆 律 师 事 务 所 青海竞帆律师事务所 股东会法律意见书 ≡曰 海 竞 帆 律 师 事 务 所 地址:青海省西宁市西关大街180号青海银行18楼 电话:0971ˉ8587800 邮编:810000 电子邮箱:jfsjⅢytd@163。coⅢ 目 录 | | 一、关于本次股东会的召集 召开程序…………….………..……4 、 | | --- | --- | | ＿ 一 、 | 关于出席本次股东会人员的资格……………………………….5 | | 二、 | 关于本次股东会的表 决程序….….……………………….·………6 | | | 四、结论意见……..…………………………………….………………………8 | ／ ／八划洲 （2025）青竞律（非诉）字第（4431）号 致:正平路桥建设股份有限公司 青海竞帆律师事务所（以下简称"本所''）接受正平路 桥建设股份有限公司（以下简称"公司"）的委托'指派李 萍、严海珍律师（以下简称''本所律师''）出席公司召开的 2025年第二次 ...

Group 1 - The core point of the article is that *ST Zhengping has announced a pre-restructuring debt claim declaration involving the parent company and 13 subsidiaries, with a deadline for claims submission set for January 25, 2026, using both online and paper mailing methods [1] - This debt claim declaration is partial, and important controlling subsidiaries are not included, leading to uncertainties regarding the accuracy and completeness of the claims, which may not eliminate the non-standard opinion issues for 2024 [1] - As of the end of the third quarter of 2025, the company's net assets attributable to the parent company are 280 million yuan, but there are asset impairment issues and undisclosed liabilities that could result in negative audited net assets, posing a risk of delisting [1] Group 2 - The company's stock price has shown significant fluctuations, with a large increase from the beginning of the year to November 18, detaching from the fundamentals, prompting a warning for investors to be cautious of risks [1]

Market Performance - The infrastructure sector increased by 0.45% compared to the previous trading day, with Guosheng Technology leading the gains [1] - The Shanghai Composite Index closed at 3959.62, up 0.47%, while the Shenzhen Component Index closed at 13531.41, up 0.33% [1] Top Gainers in Infrastructure Sector - Guosheng Technology (603778) closed at 15.89, up 6.15%, with a trading volume of 977,400 shares and a transaction value of 1.528 billion [1] - ST Zhengping (603843) closed at 4.73, up 5.11%, with a trading volume of 20,800 shares and a transaction value of 9.8249 million [1] - Dongzhu Ecology (603359) closed at 8.64, up 5.11%, with a trading volume of 308,800 shares and a transaction value of 263 million [1] Market Trends and Capital Flow - The infrastructure sector experienced a net outflow of 88.965 million from institutional investors, while retail investors saw a net inflow of 127 million [2] - The top stocks with significant net inflows from retail investors include China Nuclear Engineering (601611) with a net inflow of 1.15 billion [3] - The overall capital flow indicates a mixed sentiment, with institutional investors withdrawing while retail investors are actively buying [2][3]

Group 1 - Guangqi Technology's controlling shareholder proposed a share buyback of 50 million to 100 million yuan for employee stock ownership plans or equity incentives [1] - Xingyuan Zhuomai received a supplier designation from a domestic electric vehicle manufacturer to develop and supply reducer shell components, with expected sales of approximately 575 million yuan over four years from 2027 to 2030 [2] - Weigao Bio's application for clinical trials of subcutaneous human immunoglobulin has been accepted by the National Medical Products Administration, targeting primary immunodeficiency diseases [3] Group 2 - Hongda Electronics disclosed uncertainty regarding the IPO progress of its associate Jiangsu Zhanxin, in which it holds a 13.79% stake [4] - Kangchen Pharmaceutical received FDA approval to conduct clinical trials for its KC1086 project, aimed at treating advanced recurrent or metastatic solid tumors [5] - Kweichow Moutai adjusted its share buyback price ceiling to 1863.67 yuan per share, effective from December 19, 2025 [6] Group 3 - Mousse Co. announced that its controlling shareholder and actual controllers committed not to reduce their holdings within one year [7] - Tongxingbao's subsidiary signed a business contract worth 43.166 million yuan for a cloud expansion project [8] - Kaifa Electric announced plans for three shareholders to collectively reduce their holdings by 0.6999% [9] Group 4 - Longpan Technology plans to increase the production capacity of lithium iron phosphate cathode materials from 62,500 tons per year to 100,000 tons per year [10] - Zhuhai Guanyu announced plans for two shareholders to reduce their holdings by up to 3% [11] - Jiaheng Home Textiles is planning a change in control, leading to a temporary suspension of its stock [12] Group 5 - Kehua Bio's subsidiary received a medical device registration certificate for a gene polymorphism detection kit [13] - Saitex New Materials' actual controller plans to reduce holdings by up to 3% [14] - Sanhui Electric announced a shareholder's plan to reduce holdings by up to 2% [15] Group 6 - Binhua Co. plans to establish a venture capital fund with a total scale of 400 million yuan, focusing on strategic emerging industries [16] - Jindun Co. announced plans for two shareholders to reduce their holdings by up to 4% [17] - Hengdian East Magnetic's controlling shareholder plans to reduce holdings by up to 1% [18][19] Group 7 - Luxin Investment's controlling shareholder plans to reduce holdings by up to 1% [20] - Huakang Clean announced a joint bid for a hospital procurement project worth 157 million yuan [21] - Xuedilong plans to reduce its repurchased shares by up to 488,560 shares [22] Group 8 - Enhua Pharmaceutical's subsidiary signed an exclusive commercial cooperation agreement for three long-acting antipsychotic products [23] - Aier Eye Hospital plans to acquire partial equity in 39 institutions for a total of 963 million yuan [24] - Gaozheng Mining plans to acquire 100% equity of Overseas Explosives for 510 million yuan [25] Group 9 - Donghong Co. plans to repurchase shares worth 30 million to 60 million yuan for employee stock ownership plans [26] - Bear Electric's controlling shareholder plans to reduce holdings by up to 0.64% [27] - *ST Zhengping announced the initiation of pre-restructuring by the Xining Intermediate Court [28][29] Group 10 - Caesar Travel's shareholder plans to reduce holdings by up to 3% [30] - Lianchuang Electronics announced a change in controlling shareholder to Jiangxi State-owned Assets Supervision and Administration Commission [31] - Beixin Road and Bridge plans to transfer 5.33% equity in Henan Yuhang for 243 million yuan [32] Group 11 - Fenglong Co. is planning a change in control, with stock resuming trading [33]

证券代码：603843 证券简称：*ST 正平 公告编号：2025-100 正平路桥建设股份有限公司 关于法院受理预重整并指定临时管理人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重大风险提示： ●公司能否进入重整程序存在重大不确定性，公司进入预重整后能否消除非标意 见所涉事项存在重大不确定性。西宁中院决定对公司启动预重整，不代表公司正式进 入重整程序，公司也尚未收到西宁中院关于受理重整申请的相关法律文书，申请人的 重整申请能否被法院受理、公司后续是否进入重整程序均存在不确定性。公司进入预 重整程序后，仍可能难以消除非标意见所涉及的工程项目成本费用、外部借款计量的 准确性、完整性不足等事项。 ●截止目前，公司 2024 年度非标审计意见事项尚未消除，如上述非标意见所涉 事项在 2025 年度审计报告出具日前无法消除，公司股票将被终止上市。因审计范围 受限等原因，公司 2024 年年报被出具了无法表示意见的审计报告，公司股票已被实 施退市风险警示。同时，因 2024 年度内部控制被出具了否定意见的审计报告、持续 经营 ...

证券代码：603843 证券简称：*ST 正平 公告编号：2025-101 正平路桥建设股份有限公司 关于被债权人申请重整及预重整的专项自查报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重大风险提示： ●公司能否进入重整程序存在重大不确定性，公司进入预重整后能否消除非标意 见所涉事项存在重大不确定性。西宁中院决定对公司启动预重整，不代表公司正式进 入重整程序，公司也尚未收到西宁中院关于受理重整申请的相关法律文书，申请人的 重整申请能否被法院受理、公司后续是否进入重整程序均存在不确定性。公司进入预 重整程序后，仍可能难以消除非标意见所涉及的工程项目成本费用、外部借款计量的 准确性、完整性不足等事项。 ●截止目前，公司 2024 年度非标审计意见事项尚未消除，如上述非标意见所涉 事项在 2025 年度审计报告出具日前无法消除，公司股票将被终止上市。因审计范围 受限等原因，公司 2024 年年报被出具了无法表示意见的审计报告，公司股票已被实 施退市风险警示。同时，因 2024 年度内部控制被出具了否定意见的审计报告、持续 经 ...

Core Viewpoint - The company, *ST Zhengping, is facing potential restructuring as it has been unable to meet its debt obligations and lacks the capacity to repay, leading to a court application for pre-restructuring [1] Group 1 - The company received a notification from the Intermediate People's Court of Xining, Qinghai Province, regarding an application for pre-restructuring by creditor Nanchang Yindu Small and Medium Enterprises Service Co., Ltd. [1] - The court officially accepted the pre-restructuring application on December 24, 2025, but this does not indicate that the company has formally entered the restructuring process [1] - There is significant uncertainty regarding whether the company will proceed to formal restructuring [1]

Core Viewpoint - The company *ST Zhengping is facing significant financial distress, with creditors applying for reorganization due to the company's inability to repay debts and a clear lack of repayment capacity [1] Group 1: Financial Situation - The company officially entered pre-reorganization on December 24, 2023, following the creditor's application [1] - There is substantial uncertainty regarding the company's ability to enter the reorganization process [1] Group 2: Audit and Stock Status - The 2024 annual report is expected to receive an audit report that expresses an inability to provide an opinion, which poses risks for the company's future [1] - The company's stock has been placed under delisting risk warning, and if issues related to the non-standard opinion are not resolved before the 2025 audit report, the stock will be terminated from listing [1] Group 3: Stock Performance - The company's stock has experienced irrational speculation, with a cumulative increase of 24.65% since the beginning of the year and a remarkable increase of 221.93% from September 1 to November 18 [1]